These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3677005)

  • 1. Malignant lymphomas of follicular center cell origin in man. VI. Large cleaved cell lymphoma.
    Stein RS; Magee MJ; Lenox RK; Cousar JB; Collins RD; Flexner JM; Ray W; Greer JP
    Cancer; 1987 Dec; 60(11):2704-11. PubMed ID: 3677005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-cell lymphomas: clinical and prognostic features.
    Stein RS; Greer JP; Flexner JM; Hainsworth JD; Collins RD; Macon WR; Cousar JB
    J Clin Oncol; 1990 Aug; 8(8):1370-9. PubMed ID: 2199623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Ann Intern Med; 1988 Dec; 109(12):939-45. PubMed ID: 3057985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan.
    Dunn P; Kuo TT; Shih LY; Lin TL; Wang PN; Kuo MC; Tang CC
    Acta Haematol; 2004; 112(4):203-8. PubMed ID: 15564732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
    Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
    J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
    Tezcan H; Vose JM; Bast M; Bierman PJ; Kessinger A; Armitage JO
    Leuk Lymphoma; 1999 Jul; 34(3-4):273-85. PubMed ID: 10439364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.
    Bennett JM; Cain KC; Glick JH; Johnson GJ; Ezdinli E; O'Connell MJ
    J Clin Oncol; 1986 Oct; 4(10):1462-9. PubMed ID: 3531421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
    Mac Manus MP; Hoppe RT
    J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome and prognostic factors for primary nasal lymphoma.
    Liang R; Todd D; Chan TK; Chiu E; Lie A; Kwong YL; Choy D; Ho FC
    J Clin Oncol; 1995 Mar; 13(3):666-70. PubMed ID: 7884427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.
    Greer JP; Macon WR; Lamar RE; Wolff SN; Stein RS; Flexner JM; Collins RD; Cousar JB
    J Clin Oncol; 1995 Jul; 13(7):1742-50. PubMed ID: 7602364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular non-Hodgkin's lymphoma in Hong Kong Chinese: a retrospective analysis.
    Liang R; Todd D; Chan TK; Ng RP; Choy D; Loke SL; Ho FC
    Hematol Oncol; 1988; 6(1):29-37. PubMed ID: 3343027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of non-Hodgkin's lymphoma.
    Coffey J; Hodgson DC; Gospodarowicz MK
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S28-36. PubMed ID: 12692688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.
    Pan D; Qin J; Farber C; O'Brien J; Filippa D; Portlock CS
    Leuk Lymphoma; 2003 Jun; 44(6):967-71. PubMed ID: 12854895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant lymphomas of follicular centre cell origin in man. VII. Prognostic features in small cleaved cell lymphoma.
    Stein RS; Greer JP; Cousar JB; Hendey GW; Wehner JH; Flexner JM; Collins RD
    Hematol Oncol; 1989; 7(5):381-91. PubMed ID: 2475420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.